Ofev (nintedanib) is a capsule used to slow the rate of decline in lung function for adults with specific chronic fibrosing interstitial lung diseases (ILDs) that cause progressive lung scarring. It is approved for Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-associated ILD (SSc-ILD), and other progressive fibrosing ILDs.
$755.00–$3,737.00Price range: $755.00 through $3,737.00Select options
This product has multiple variants. The options may be chosen on the product page